Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decrease in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 69 shares, a decline of 90.6% from the May 14th total of 734 shares. Based on an average daily trading volume, of 2,285 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of NYSEARCA:BOUT traded down $0.21 during trading hours on Tuesday, hitting $45.75. 1,060 shares of the company’s stock traded hands, compared to its average volume of 4,551. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $48.05. The business has a fifty day moving average price of $44.42 and a 200-day moving average price of $40.56. The firm has a market capitalization of $16.01 million, a P/E ratio of 28.69 and a beta of 1.04.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

A number of large investors have recently modified their holdings of the company. Susquehanna International Group LLP boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares during the period. Comprehensive Wealth Management LLC boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the period. Finally, Osaic Holdings Inc. boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.